Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. QuVa Pharma, Inc.
483
•QuVa Pharma, Inc.•June 2, 2017

QuVa Pharma, Inc. – FDA 483, Jun 2, 2017

Record Details

During an FDA inspection on May 23, 2017, at an unnamed facility, an observation was made regarding the manufacturing of sterile drug products. The observation noted that procedures designed to prevent microbiological contamination were not followed. Specifically, three out of an unspecified number of production technicians were observed resting their elbows on the front areas of multiple laminar airflow hoods while producing sterile drug products.

This behavior occurred during the production of three specific drug products: 1. Ropivacaine HCL PF 0.2%, 2mg/mL, Lot #10003990. NS 200 mL in 250 mL, Cassette (400 mg). This was produced by technician one in clean room (b)(4) inside laminar airflow hood #3, serial (b)(4). 2. Fentanyl Citrate, PF 2mcg/mL/ Bupivacaine HCL PF 0.125% in 0.9% Sodium Chloride, 250 mL, Lot #10003982. This was produced by technician two in clean room (b)(4) inside laminar airflow hood #3, serial (b)(4). 3. Magnesium Sulfate PF 2g added to 5% Dextrose, 50 mL, Lot #10004086. This was produced by technician three in

Company
QuVa Pharma, Inc.
Inspection date
June 2, 2017
Product type
Drugs
Office
Dallas District Office
People
  • Jason R. Caballero
  • Shatina R. Alridge (Investigator)
View Company Profile

ID · 1e39698c-7d20-4ed8-ae3a-29f14b507519

Violation Codes3
21 U.S.C. 324(a)(4)FD&C Act 801(a)(3)21 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for QuVa Pharma, Inc.
  • 483 - 2022-10-14October 14, 2022
  • WARNING_LETTER - 2022-10-14October 14, 2022
  • 483 - 2022-08-18August 18, 2022
  • 483 - 2019-05-31May 31, 2019
  • 483 - 2019-04-23April 23, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore QuVa Pharma, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.